BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23629027)

  • 1. A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans.
    Jones NR; Pegues MA; McCrory MA; Singleton W; Bethune C; Baker BF; Norris DA; Crooke RM; Graham MJ; Szalai AJ
    Mol Ther Nucleic Acids; 2012 Nov; 1(11):e52. PubMed ID: 23629027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice.
    Jones NR; Pegues MA; McCrory MA; Kerr SW; Jiang H; Sellati R; Berger V; Villalona J; Parikh R; McFarland M; Pantages L; Madwed JB; Szalai AJ
    Arthritis Rheum; 2011 Sep; 63(9):2641-50. PubMed ID: 21567377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models.
    Szalai AJ; McCrory MA; Xing D; Hage FG; Miller A; Oparil S; Chen YF; Mazzone M; Early R; Henry SP; Zanardi TA; Graham MJ; Crooke RM
    Mediators Inflamm; 2014; 2014():353614. PubMed ID: 24803739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein-mediated vascular injury requires complement.
    Hage FG; Oparil S; Xing D; Chen YF; McCrory MA; Szalai AJ
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1189-95. PubMed ID: 20339115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired endothelial function in C-reactive protein overexpressing mice.
    Teoh H; Quan A; Lovren F; Wang G; Tirgari S; Szmitko PE; Szalai AJ; Ward ME; Verma S
    Atherosclerosis; 2008 Dec; 201(2):318-25. PubMed ID: 18433756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy of Mesenchymal Stromal Cells and Interleukin-4 Attenuates Rheumatoid Arthritis in a Collagen-Induced Murine Model.
    Haikal SM; Abdeltawab NF; Rashed LA; Abd El-Galil TI; Elmalt HA; Amin MA
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.
    Danenberg HD; Szalai AJ; Swaminathan RV; Peng L; Chen Z; Seifert P; Fay WP; Simon DI; Edelman ER
    Circulation; 2003 Aug; 108(5):512-5. PubMed ID: 12874178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.
    Nagai T; Anzai T; Kaneko H; Mano Y; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
    Hypertension; 2011 Feb; 57(2):208-15. PubMed ID: 21220701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CXCR5+PD-1+ T Follicular Helper Cells Play a Pivotal Role in the Development of Rheumatoid Arthritis.
    Cao G; Chi S; Wang X; Sun J; Zhang Y
    Med Sci Monit; 2019 Apr; 25():3032-3040. PubMed ID: 31019190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neointimal formation is reduced after arterial injury in human crp transgenic mice.
    Danenberg HD; Grad E; Swaminathan RV; Chen Z; Seifert P; Szalai AJ; Lotan C; Simon DI; Edelman ER
    Atherosclerosis; 2008 Nov; 201(1):85-91. PubMed ID: 18358478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antisense oligonucleotides against C-reactive protein on the development of atherosclerosis in WHHL rabbits.
    Yu Q; Liu Z; Waqar AB; Ning B; Yang X; Shiomi M; Graham MJ; Crooke RM; Liu E; Dong S; Fan J
    Mediators Inflamm; 2014; 2014():979132. PubMed ID: 24872601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent.
    Hu XZ; Wright TT; Jones NR; Ramos TN; Skibinski GA; McCrory MA; Barnum SR; Szalai AJ
    Autoimmune Dis; 2010 Oct; 2011():484936. PubMed ID: 21151582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
    Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.
    Szalai AJ; VanCott JL; McGhee JR; Volanakis JE; Benjamin WH
    Infect Immun; 2000 Oct; 68(10):5652-6. PubMed ID: 10992466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury.
    Grad E; Golomb M; Mor-Yosef I; Koroukhov N; Lotan C; Edelman ER; Danenberg HD
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H489-95. PubMed ID: 17369452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice.
    Wang D; Oparil S; Chen YF; McCrory MA; Skibinski GA; Feng W; Szalai AJ
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2094-9. PubMed ID: 16051879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.
    Nielen MM; van Schaardenburg D; Reesink HW; Twisk JW; van de Stadt RJ; van der Horst-Bruinsma IE; de Gast T; Habibuw MR; Vandenbroucke JP; Dijkmans BA
    Arthritis Rheum; 2004 Aug; 50(8):2423-7. PubMed ID: 15334453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia.
    Lee YC; Hackett J; Frits M; Iannaccone CK; Shadick NA; Weinblatt ME; Segurado OG; Sasso EH
    Rheumatology (Oxford); 2016 Apr; 55(4):640-8. PubMed ID: 26608972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab.
    Shafran IH; Alasti F; Smolen JS; Aletaha D
    Ann Rheum Dis; 2020 Jul; 79(7):874-882. PubMed ID: 32371387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.